相似文献
1
Identifying molecular drivers of gastric cancer through next-generation sequencing.
Cancer Lett. 2013 Nov 1;340(2):241-6. doi: 10.1016/j.canlet.2012.11.029. Epub 2012 Nov 20.
2
Microarray and next-generation sequencing to analyse gastric cancer.
Asian Pac J Cancer Prev. 2014;15(19):8033-9.
3
Next-generation sequencing in the clinic: promises and challenges.
Cancer Lett. 2013 Nov 1;340(2):284-95. doi: 10.1016/j.canlet.2012.11.025. Epub 2012 Nov 19.
4
Genomic sequencing in cancer.
Cancer Lett. 2013 Nov 1;340(2):161-70. doi: 10.1016/j.canlet.2012.11.004. Epub 2012 Nov 23.
5
Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
J Transl Med. 2019 Jun 4;17(1):189. doi: 10.1186/s12967-019-1941-0.
6
Fusion genes and their discovery using high throughput sequencing.
Cancer Lett. 2013 Nov 1;340(2):192-200. doi: 10.1016/j.canlet.2013.01.011. Epub 2013 Jan 29.
7
Analyzing the cancer methylome through targeted bisulfite sequencing.
Cancer Lett. 2013 Nov 1;340(2):171-8. doi: 10.1016/j.canlet.2012.10.040. Epub 2012 Nov 28.
8
Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.
Cancer Lett. 2013 Nov 1;340(2):227-33. doi: 10.1016/j.canlet.2012.11.008. Epub 2012 Nov 27.
9
Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
Cancer Lett. 2013 Nov 1;340(2):152-60. doi: 10.1016/j.canlet.2012.10.018. Epub 2012 Oct 27.
10
Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Cancer Lett. 2013 Nov 1;340(2):247-53. doi: 10.1016/j.canlet.2012.09.027. Epub 2012 Oct 12.
引用本文的文献
1
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications.
Eur J Med Res. 2025 Feb 12;30(1):98. doi: 10.1186/s40001-025-02353-5.
2
Genomic characterization of peritoneal lavage cytology-positive gastric cancer.
Chin J Cancer Res. 2024 Feb 29;36(1):66-77. doi: 10.21147/j.issn.1000-9604.2024.01.07.
3
The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS.
BMC Gastroenterol. 2023 May 15;23(1):153. doi: 10.1186/s12876-023-02765-9.
4
Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential.
Cells. 2023 May 4;12(9):1314. doi: 10.3390/cells12091314.
5
Detection of circulating stage III-IV gastric cancer tumor cells based on isolation by size of epithelial tumor: using the circulating tumor cell biopsy technology.
Transl Cancer Res. 2019 Aug;8(4):1342-1350. doi: 10.21037/tcr.2019.07.32.
6
Apatinib in Combination with S-1 as First-Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single-Arm, Phase II Trial.
Oncologist. 2021 Mar;26(3):e374-e381. doi: 10.1002/onco.13613. Epub 2020 Dec 28.
7
Genetic profiling of somatic alterations by Oncomine Focus Assay in Korean patients with advanced gastric cancer.
Oncol Lett. 2020 Nov;20(5):129. doi: 10.3892/ol.2020.11990. Epub 2020 Aug 20.
8
High-Throughput Sequencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype.
Cancers (Basel). 2020 Jul 21;12(7):1981. doi: 10.3390/cancers12071981.
9
Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats.
Drug Des Devel Ther. 2020 Jun 9;14:2207-2219. doi: 10.2147/DDDT.S247958. eCollection 2020.
10
Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis.
Clin Transl Med. 2020 Jan;10(1):353-362. doi: 10.1002/ctm2.32.
本文引用的文献
1
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
Genome Res. 2012 Nov;22(11):2120-9. doi: 10.1101/gr.137596.112. Epub 2012 Oct 1.
2
Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer.
Chin J Cancer. 2012 Oct;31(10):463-70. doi: 10.5732/cjc.012.10216. Epub 2012 Sep 17.
3
AMPKα2 Suppresses Murine Embryonic Fibroblast Transformation and Tumorigenesis.
Genes Cancer. 2012 Jan;3(1):51-62. doi: 10.1177/1947601912452883.
4
Overcoming implementation challenges of personalized cancer therapy.
Nat Rev Clin Oncol. 2012 Sep;9(9):542-8. doi: 10.1038/nrclinonc.2012.127. Epub 2012 Jul 31.
5
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
Nat Genet. 2012 May;44(5):570-4. doi: 10.1038/ng.2246.
6
AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.
Cancer Res. 2012 May 15;72(10):2512-21. doi: 10.1158/0008-5472.CAN-11-3870. Epub 2012 Mar 20.
7
miRNA arm selection and isomiR distribution in gastric cancer.
BMC Genomics. 2012;13 Suppl 1(Suppl 1):S13. doi: 10.1186/1471-2164-13-S1-S13. Epub 2012 Jan 17.
8
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.
Nat Genet. 2011 Oct 30;43(12):1219-23. doi: 10.1038/ng.982.
9
Gastric cancer: basic aspects.
Helicobacter. 2011 Sep;16 Suppl 1:38-44. doi: 10.1111/j.1523-5378.2011.00879.x.
10
Trend in gastric cancer: 35 years of surgical experience in Japan.
World J Gastroenterol. 2011 Aug 7;17(29):3390-7. doi: 10.3748/wjg.v17.i29.3390.
Zotero 插件